159 related articles for article (PubMed ID: 33680119)
1.
Mao J; Tan Z; Pan X; Meng F
Exp Ther Med; 2021 Apr; 21(4):397. PubMed ID: 33680119
[TBL] [Abstract][Full Text] [Related]
2. ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma.
Yang T; Gao Y; Liu D; Wang Y; Wu J; Liu X; Shi Y; Chen D
Biochem Biophys Res Commun; 2019 Jan; 508(3):769-774. PubMed ID: 30528232
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of ASPP2 improves hepatocellular carcinoma cells survival via promoting BECN1-dependent autophagy initiation.
Chen R; Wang H; Liang B; Liu G; Tang M; Jia R; Fan X; Jing W; Zhou X; Wang H; Yang Y; Wei H; Li B; Zhao J
Cell Death Dis; 2016 Dec; 7(12):e2512. PubMed ID: 27929538
[TBL] [Abstract][Full Text] [Related]
4. [Effect of transcatheter arterial chemoembolization combined with thymosin alpha 1 on the autophagy of immune cells from advanced hepatocellular carcinoma].
Fang SJ; Zheng LY; Zhao ZW; Fan XX; Xu M; Ji JS
Zhonghua Yi Xue Za Zhi; 2017 Jul; 97(25):1942-1946. PubMed ID: 28693071
[No Abstract] [Full Text] [Related]
5. Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization.
Guo Z; Wang J; Li L; Liu R; Fang J; Tie B
World J Clin Cases; 2020 Aug; 8(16):3493-3502. PubMed ID: 32913856
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter arterial chemoembolization combined with interferon-α is safe and effective for patients with hepatocellular carcinoma after curative resection.
Zuo CH; Xia M; Liu JS; Qiu XX; Lei X; Xu RC; Liu HC; Li JL; Li YG; Li QL; Xiao H; Hong Y; Wang XH; Zhu HZ; Wu QF; Burns M; Liu C
Asian Pac J Cancer Prev; 2015; 16(1):245-51. PubMed ID: 25640360
[TBL] [Abstract][Full Text] [Related]
7. Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization.
Xiao EH; Li JQ; Huang JF
World J Gastroenterol; 2004 Jan; 10(2):190-4. PubMed ID: 14716820
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma.
Chen MY; Juengpanich S; Hu JH; Topatana W; Cao JS; Tong CH; Lin J; Cai XJ
World J Gastroenterol; 2020 Mar; 26(10):1042-1055. PubMed ID: 32205995
[TBL] [Abstract][Full Text] [Related]
10. β-Catenin Expression Correlates With Prognosis in Hepatocellular Carcinoma Patients Treated With Transcatheter Arterial Chemoembolization.
Xu X; Gao D; Yuan X; Liu LI; Zhang X; Liang X; Chen S; Ai M; Chen BO; Shi D; Yang Z; Hoffman RM; Xu J
Anticancer Res; 2019 Mar; 39(3):1129-1134. PubMed ID: 30842141
[TBL] [Abstract][Full Text] [Related]
11. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
[TBL] [Abstract][Full Text] [Related]
12. The Negative Effect of Preoperative Transcatheter Arterial Chemoembolization on Long-Term Outcomes for Resectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Amisaki M; Honjo S; Morimoto M; Hanaki T; Arai Y; Tokuyasu N; Sakamoto T; Ohuchi Y; Saito H
Yonago Acta Med; 2016 Dec; 59(4):270-278. PubMed ID: 28070164
[TBL] [Abstract][Full Text] [Related]
13. Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction.
Kaibori M; Tanigawa N; Matsui Y; Saito T; Uchida Y; Ishizaki M; Tanaka H; Kamiyama Y
Anticancer Res; 2006; 26(5B):3685-92. PubMed ID: 17094386
[TBL] [Abstract][Full Text] [Related]
14. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis.
Li C; Wang MD; Lu L; Wu H; Yu JJ; Zhang WG; Pawlik TM; Zhang YM; Zhou YH; Gu WM; Wang H; Chen TH; Han J; Xing H; Li ZL; Lau WY; Wu MC; Shen F; Yang T
Hepatol Int; 2019 Nov; 13(6):736-747. PubMed ID: 31486964
[TBL] [Abstract][Full Text] [Related]
15. Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients.
Huang YH; Wu JC; Chau GY; Lui WY; King KL; Chiang JH; Yen SH; Sheng WY; Hou MC; Lu CL; Chang FY; Lee SD
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):315-21. PubMed ID: 10333206
[TBL] [Abstract][Full Text] [Related]
16. PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma.
Martin SP; Fako V; Dang H; Dominguez DA; Khatib S; Ma L; Wang H; Zheng W; Wang XW
J Exp Clin Cancer Res; 2020 Jun; 39(1):99. PubMed ID: 32487192
[TBL] [Abstract][Full Text] [Related]
17. Proteoglycan-4 predicts good prognosis in patients with hepatocellular carcinoma receiving transcatheter arterial chemoembolization and inhibits cancer cell migration
Guo Y; Hu HT; Xu SJ; Xia WL; Zhao Y; Zhao XH; Zhu WB; Li FT; Li HL
Front Oncol; 2022; 12():1023801. PubMed ID: 36439456
[TBL] [Abstract][Full Text] [Related]
18. Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma.
Wang JH; Zhong XP; Zhang YF; Wu XL; Li SH; Jian PE; Ling YH; Shi M; Chen MS; Wei W; Guo RP
Cell Death Dis; 2017 Sep; 8(9):e3043. PubMed ID: 28880268
[TBL] [Abstract][Full Text] [Related]
19. The response of Golgi protein 73 to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma may relate to the influence of certain chemotherapeutics.
Pan J; Zhang YF; Yang HY; Xu HF; Lu X; Sang XT; Zhong SX; Mao YL
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):406-12. PubMed ID: 26256086
[TBL] [Abstract][Full Text] [Related]
20. Pathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection.
Paik KY; Kim EK
Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):158-64. PubMed ID: 27020632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]